Phase II trial of gefitinib inpatients with incurable salivary gland cancer.

被引：0
|
作者：
Glisson, BS [1 ]
Blumenschein, G [1 ]
Francisco, M [1 ]
Erasmus, J [1 ]
Zinner, R [1 ]
Kies, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508S / 508S
页数：1
相关论文
共 50 条
  • [31] Early clinical results of a phase II trial evaluating neoadjuvant chemotherapy followed by chemoradiation and maintenance gefitinib in locally advanced cervical cancer.
    Benson, Rony
    Pathy, Sushmita
    Kumar, Lalit
    Mathur, Sandeep
    Pandey, Rabindra
    Chander, Subhash
    Dadhwal, Vatsla
    Mohanti, B. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Gefitinib does not improve the efficacy and enhances the toxicity of folfiri regimen in patients with metastatic colorectal cancer. A randomized multicenter phase ii trial
    Carnaghi, Carlo
    Comandone, Alessandro
    Lo Russo, Vito
    Merlano, Marco Carlo
    Villa, Eugenio
    Siena, Salvatore
    Lombardo, Marco
    Agostara, Biagio
    Paccagnella, Adriano
    Rimassa, Lorenza
    Mari, Ettore
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2007, 18 : 19 - 19
  • [33] Expression of CXCR4 in human salivary gland cancer.
    Begum, Nasima-Mila
    Uchida, Daisuke
    Nakashiro, Koh-Ichi
    Tomizuka, Yoshifumi
    Onoue, Tomitaro
    Yoshida, Hideo
    Sato, Mitsunobu
    CANCER RESEARCH, 2006, 66 (08)
  • [34] Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma - A phase II trial of 22 patients
    Licitra, L
    Cavina, R
    Grandi, C
    DiPalma, S
    Guzzo, M
    Demicheli, R
    Molinari, R
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 640 - 642
  • [35] Preliminary results of a phase lb trial of savolitinib combined with gefitinib in EGFR-mutant lung cancer.
    Yang, Jin-Ji
    Yang, Liu
    Farnsworth, Andrew
    Handzel, Amir
    Coleman, Tanya
    Morgan, Shethah
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract
    Locati, Laura D.
    Cavalieri, Stefano
    Bergamini, Cristiana
    Resteghini, Carlo
    Alfieri, Salvatore
    Calareso, Giuseppina
    Bossi, Paolo
    Perrone, Federica
    Tamborini, Elena
    Quattrone, Pasquale
    Granata, Roberta
    Galbiati, Donata
    Platini, Francesca
    Orlandi, Ester
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (10): : 3670 - 3676
  • [37] FEASIBILITY OF SURGERY FOLLOWED BY CHEMORADIOTHERAPY IN GASTRIC CANCER. PHASE II TRIAL
    Michel, P.
    Bonnetain, F.
    Perverge, D.
    Saurin, J. C.
    Faroux, R.
    Benchellal, Z.
    Aparicio, T.
    Dahan, L.
    Bedenne, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 241 - 241
  • [38] Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial
    Locati, Laura D.
    Cavalieri, Stefano
    Bergamini, Cristiana
    Resteghini, Carlo
    Colombo, Elena
    Calareso, Giuseppina
    Mariani, Luigi
    Quattrone, Pasquale
    Alfieri, Salvatore
    Bossi, Paolo
    Platini, Francesca
    Capone, Iolanda
    Licitra, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4061 - +
  • [39] A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer.
    Ling, Huichung Tina
    Muggia, Franco
    Speyer, James L.
    Curtin, John Patrick
    Blank, Stephanie V.
    Boyd, Leslie R.
    Pothuri, Bhavana
    Li, Xiaochun
    Goldberg, Judith D.
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Phase Ib/II trial of lenvatinib plus pembrolizumab in urothelial cancer.
    Vogelzang, Nicholas J.
    Encarnacion, Carlos A.
    Cohn, Allen Lee
    DiSimone, Christopher
    Rasco, Drew W.
    Richards, Donald A.
    Taylor, Matthew H.
    Dutcus, Corina E.
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Guo, Matthew
    Schmidt, Emmett V.
    Mier, James Walter
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345